Novonesis provides outlook for 2024 with expected 5-7% organic sales growth and ~35% adj. EBITDA margin. Pro forma financials disclosed. Ester Baiget, CEO of Novonesis, said: “Today we provide key pro ...

The unaudited pro forma condensed combined statements of income and comprehensive income combine the audited consolidated statement of income and comprehensive income of GCL for the year ended March ...

The MarketWatch News Department was not involved in the creation of this content. SINGAPORE, Aug. 29, 2025 (GLOBE NEWSWIRE) -- GCL Global Holdings Ltd (NASDAQ: GCL) ("GCL" or the "Company"), a leading ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

Sunoco LP (NYSE:SUN) filed an amendment Friday to its previous Form 8-K, providing updated unaudited pro forma condensed combined financial information following its acquisition of Parkland ...

Xerox Holdings Corporation (NASDAQ:XRX) filed unaudited financial statements and pro forma combined financial information related to its acquisition of Lexmark International II, LLC with the ...

PainReform ( (PRFX)) has provided an update. On January 7, 2026, PainReform Ltd. filed a Form 6-K in the United States providing updated financial disclosure related to its acquisition of LayerBio Inc ...